About: A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece
Creator	Argyraki, Aikaterini Boletis, Ioannis Grigorakos, Konstantinos Lourida, Panayiota Marinaki, Smaragdi Skalioti, Chrysanthi Tsiakas, Stathis
Source	PMC
abstract	The evolving pandemic of Coronavirus Disease 2019 has posed a substantial health risk worldwide. However, there is a paucity of data regarding the clinical course and the therapeutic management of patients with chronic kidney disease and COVID-19 infection. To date, most evidence has come from renal transplantation, with about 45 patients reported thus far, and the current data from the ERA-EDTA (ERACODA) registry for transplanted patients and patients on Renal Replacement Therapy (RRT); as for those with glomerular diseases, data are lacking. Herein, we report the case of a 62-year-old patient with severe membranoproliferative glomerulonephritis who had been receiving a high burden of immunosuppression until four months before the COVID-19 infection. He developed severe disease with acute respiratory failure requiring mechanical ventilation. After treatment with hydroxychloroquine and azithromycin, despite his low chances, he gradually recovered and survived. To the best of our knowledge, this is one of the few reported patients with glomerulonephritis who had COVID-19 Besides our single case with glomerulonephritis early during the disease outbreak, the very low prevalence of COVID-19 infection in the country’s transplant recipients (0.038%) and dialysis patients (0.24%) reflects the impact of the rapid implementation of social distancing rules as well as of preventive measures for disease control in the hospitals and dialysis units in our country.
has issue date	2020-07-17(xsd:dateTime)
bibo:doi	10.3390/medicina56070355
bibo:pmid	32708858
has license	cc-by
sha1sum (hex)	2284557ab3f289a86f85bda35a79661315037128
schema:url	https://doi.org/10.3390/medicina56070355
resource representing a document's title	A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece
has PubMed Central identifier	PMC7404464
has PubMed identifier	32708858
schema:publication	Medicina (Kaunas)
resource representing a document's body	covid:2284557ab3f289a86f85bda35a79661315037128#body_text
is schema:about of	named entity 'preventive' named entity 'azithromycin' named entity 'mechanical ventilation' named entity 'patients' named entity 'However' named entity 'CASE' named entity 'CORONAVIRUS DISEASE 2019' named entity 'COVID-19' named entity 'DISEASE CONTROL' named entity 'AFTER TREATMENT' named entity 'RECOVERED' named entity 'EDTA' named entity 'IMPLEMENTATION' named entity 'CHRONIC KIDNEY DISEASE' named entity 'VERY LOW' named entity 'REFLECTS' named entity 'HIGH' named entity 'gradually' named entity 'data' named entity 'chances' named entity 'impact' named entity 'After' named entity 'Disease' named entity 'COVID-19' named entity 'acute respiratory failure' named entity 'RRT' named entity 'immunosuppression' named entity 'dialysis' named entity 'disease outbreak' named entity 'COVID' named entity 'infection' named entity 'health risk' named entity 'infection' named entity 'hydroxychloroquine' named entity 'COVID' named entity 'COVID-19' named entity 'COVID-19' named entity 'Dialysis' named entity 'immunosuppression' named entity 'general population' named entity 'tele-medicine' named entity 'dry cough' named entity 'renal function' named entity 'stage III' named entity 'infection' named entity 'kidney transplant' named entity 'throat swab' named entity '24 May' named entity 'nephrology' named entity 'Case Fatality Rate' named entity 'Case Fatality Rate' named entity 'dialysis' named entity 'infection' named entity 'virus infection' named entity 'cyclophosphamide' named entity 'immunosuppressive treatment' named entity 'B-cells' named entity 'COVID' named entity 'cyclophosphamide' named entity 'Handwashing' named entity 'Eurozone' named entity 'Eurozone' named entity 'renal transplantation' named entity 'COVID-19' named entity 'immunosuppressive' named entity 'COVID' named entity 'infection' named entity 'coronavirus' named entity 'virus' named entity 'first-line treatment' named entity 'risk factors' named entity 'European Centre for Disease Prevention and Control' named entity 'kidney transplant' named entity 'MPGN' named entity 'asymptomatic'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software